
As reported by NR Times last week, Bioxtreme has secured a total of US$15m to support the development of its rehab robotics.
Here, we speak to Eyal Samuel Shachar, CEO of BioXtreme, about the company’s counterintuitive approach to neurorehabilitation: using error augmentation in robotics to help stroke and other neurological injury patients recover faster.
Watch the exclusive interview now on YouTube or listen on your chosen podcast platform.








